Augmedix Stock Total Debt
Augmedix fundamentals help investors to digest information that contributes to Augmedix's financial success or failures. It also enables traders to predict the movement of Augmedix Stock. The fundamental analysis module provides a way to measure Augmedix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Augmedix stock.
Augmedix |
Augmedix Company Total Debt Analysis
Augmedix's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Augmedix Total Debt | 25.85 M |
Most of Augmedix's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Augmedix has a Total Debt of 25.85 M. This is 99.06% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 99.51% higher than that of the company.
Augmedix Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Augmedix's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics of similar companies.Augmedix is currently under evaluation in total debt category among its peers.
Augmedix Fundamentals
Return On Equity | -3.3 | |||
Return On Asset | -0.31 | |||
Profit Margin | (0.46) % | |||
Operating Margin | (0.64) % | |||
Current Valuation | 113.21 M | |||
Shares Outstanding | 49.43 M | |||
Shares Owned By Insiders | 1.50 % | |||
Shares Owned By Institutions | 84.78 % | |||
Number Of Shares Shorted | 1.07 M | |||
Price To Book | 11.09 X | |||
Price To Sales | 2.25 X | |||
Revenue | 44.85 M | |||
Gross Profit | 13.95 M | |||
EBITDA | (17.68 M) | |||
Net Income | (19.17 M) | |||
Cash And Equivalents | 29.99 M | |||
Cash Per Share | 0.80 X | |||
Total Debt | 25.85 M | |||
Debt To Equity | 1.54 % | |||
Current Ratio | 2.89 X | |||
Book Value Per Share | 0.21 X | |||
Cash Flow From Operations | (15.44 M) | |||
Short Ratio | 5.73 X | |||
Earnings Per Share | (0.47) X | |||
Target Price | 2.92 | |||
Number Of Employees | 1.43 K | |||
Beta | -0.19 | |||
Market Capitalization | 116.16 M | |||
Total Asset | 66.71 M | |||
Retained Earnings | (144.96 M) | |||
Working Capital | 33.2 M | |||
Net Asset | 66.71 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |